WHO's Covaxin Clearance Delayed Over Queries

PUBLISHED ON: September 28, 2021 | Duration: 8 min, 38 sec

  
loading..
The World Health Organization (WHO) has further delayed the emergency use authorisation (EUA) for Covaxin, the Covid vaccine developed in India, as the global body has sent more technical queries to its manufacturer Bharat Biotech, according to sources. This delay is likely to adversely affect Indians', especially students', international travel plans. Without the EUA, Covaxin will not be considered an accepted vaccine by most countries around the world. WHO's queries for Bharat Biotech comes despite the Hyderabad-based drug maker asserting that it has submitted all data required for clearance.
ALSO WATCH
विदेश सचिव ने जताई उम्‍मीद, बोले- कोवैक्‍सीन को जल्‍द मिलेगी WHO से मंजूरी

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com